Neurobiological NTII Stock
0.0001 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
OTC Markets EXMKT
Market Cap
5.43M USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
1.1K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Neurobiological Price Chart
Neurobiological NTII Financial and Trading Overview
| Neurobiological stock price | 0.0001 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.0001 USD |
| Volume | 2 USD |
| Avg. Volume | 0 USD |
| Market Cap | 54.31K USD |
| Beta (5Y Monthly) | -40.384857 |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NTII Valuation Measures
| Enterprise Value | -25994972 USD |
| Trailing P/E | Infinity |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.0021449053 |
| Price/Book (mrq) | 9.328358E-7 |
| Enterprise Value/Revenue | -1.027 |
| Enterprise Value/EBITDA | -1.33 |
Trading Information
Neurobiological Stock Price History
| Beta (5Y Monthly) | -40.384857 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
NTII Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 27.02M |
| Float | N/A |
| Short Ratio | 0.09 |
| % Held by Insiders | 0% |
| % Held by Institutions | 9.41% |
| Shares Short | 37.6K |
| Short % of Float | 0.33% |
| Short % of Shares Outstanding | 0.13% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2009 |
| Most Recent Quarter (mrq) | December 17, 2009 |
| Next Fiscal Year End | June 30, 2010 |
Profitability
| Profit Margin | 73.71% |
| Operating Margin (ttm) | 76.97% |
| Gross Margin | 100.00% |
| EBITDA Margin | 77.17% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | 99.71% |
Income Statement
| Revenue (ttm) | 25.32M USD |
| Revenue Per Share (ttm) | 0.94 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 26.35M USD |
| EBITDA | 19.54M USD |
| Net Income Avi to Common (ttm) | 18.67M USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 26.49M USD |
| Total Cash Per Share (mrq) | 0.98 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 1.072 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3692000 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Neurobiological
| Country | United States |
| State | CA |
| City | EmeryVille |
| Address | 2000 Powell Street |
| ZIP | 94608 |
| Phone | 510 595 6000 |
| Website | N/A |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.
Q&A For Neurobiological Stock
What is a current NTII stock price?
Neurobiological NTII stock price today per share is 0.0001 USD.
How to purchase Neurobiological stock?
You can buy NTII shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Neurobiological?
The stock symbol or ticker of Neurobiological is NTII.
Which industry does the Neurobiological company belong to?
The Neurobiological industry is Biotechnology.
How many shares does Neurobiological have in circulation?
The max supply of Neurobiological shares is 54.31B.
What is Neurobiological Price to Earnings Ratio (PE Ratio)?
Neurobiological PE Ratio is now.
What was Neurobiological earnings per share over the trailing 12 months (TTM)?
Neurobiological EPS is 0 USD over the trailing 12 months.
Which sector does the Neurobiological company belong to?
The Neurobiological sector is Healthcare.